Evolus Stock News

NEWPORT BEACH, Calif.--(BUSINESS WIRE)---- $EOLS--Evolus announces that it will report its first quarter 2022 financial results and provide a business update on Tuesday, May 10, 2022.

Evolus Inc. (NASDAQ:EOLS) shares, rose in value on Friday, 03/11/22, with the stock price down by -4.10% to the previous day’s close as strong demand from buyers drove the stock to $10.07. Actively observing the price movement in the last trading, the stock closed the session at $10.50, falling within a range of $10.05 and … The Evolus Inc. (NASDAQ: EOLS) Stock Price: Is It Overvalued? Read More »

NEWPORT BEACH, Calif.--(BUSINESS WIRE)---- $EOLS--Evolus announces that members of its management team will be participating in the Barclays Global Healthcare Conference.

NEWPORT BEACH, Calif.--(BUSINESS WIRE)---- $EOLS--Evolus announces that members of its management team will be participating in the Barclays Global Healthcare Conference.

Small cap Evolus Inc. ( EOLS , Financial) is thinking big, and analysts agree the company can continue to make headway in the $2 billion U.S. market for aesthetics. The 10-year-old Newport Beach, Cali

Evolus Inc''s (NASDAQ: EOLS ) Q4 FY21 sales increased 68% Y/Y to $34.7 million in line with interim results , beating the consensus of $33.99 million, driven by higher volumes and average selling price. Adjusted gross profit margin declined from 64.6% to 54.3%, impacted by the higher settlement royalty rates in effect until September 2022. Non-GAAP loss from operations was $(12.2) million and was … Full story available on Benzinga.com

Evolus, Inc. (EOLS) delivered earnings and revenue surprises of -45% and 0.12%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?

Evolus' (EOLS) CEO David Moatazedi on Q4 2021 Results - Earnings Call Transcript

Evolus press release (NASDAQ:EOLS): Q4 GAAP EPS of -$0.33 beats by $0.07.Revenue of $34.7M (+68.6% Y/Y) misses by $0.07M.

Evolus (EOLS) said Lauren Silvernail will retire from her role as CFO and EVP of corporate development effective May 31, after nearly 4 years with the company.The search for her…

NEWPORT BEACH, Calif.--(BUSINESS WIRE)---- $EOLS--Evolus reports financial results for the fourth quarter and full-year ended December 31, 2021 and provides a business update.

Evolus, Inc. (EOLS) delivered earnings and revenue surprises of -45% and 0.12%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?

Evolus (NASDAQ:EOLS) is scheduled to announce Q4 earnings results on Thursday, March 3rd, after market close.The consensus EPS Estimate is -$0.19 (+94.2% Y/Y) and the consensus…

BioLife Solutions, Inc. (BLFS) delivered earnings and revenue surprises of -131.25% and 0.06%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the s